滋养外胚层活检与冻融囊胚移植单胎活产中中至极度早产及低出生体重风险降低相关:一项全国登记队列研究
基于美国2014至2017年辅助生殖技术全国登记库45,712例自体冻融囊胚移植单胎活产,比较滋养外胚层活检组(n=21,584)与无活检组(n=24,128)。活检与低出生体重<2500g、极低出生体重<1500g、超低出生体重<1000g、中度早产<34周及极度早产<28周风险显著降低相关,与小于胎龄儿、大于胎龄儿及晚期早产<37周无显著关联。
要点
- 滋养外胚层活检与低出生体重<2500g风险降低相关(校正OR 0.80,95%CI 0.70-0.92,P<.001)。
- 活检与极低出生体重<1500g、超低出生体重<1000g风险降低相关(校正OR分别为0.62、0.48)。
- 活检与中度早产<34周、极度早产<28周风险降低相关(校正OR分别为0.76、0.63)。
核心结论
- 滋养外胚层活检不增加小于胎龄儿、大于胎龄儿或晚期早产<37周的风险。
- 活检后低出生体重、极低出生体重、超低出生体重以及中度早产和极度早产的风险更低,可能通过排除局限性胎盘嵌合体或诱导胎盘表观遗传改变实现,其机制需进一步研究。
研究设计与样本
- 回顾性观察性队列研究,纳入2014至2017年向美国辅助生殖技术学会全国登记库报告的自体冻融囊胚移植单胎活产45,712例,按是否行滋养外胚层活检分组。
- 活检组n=21,584,无活检组n=24,128,采用多变量回归分析控制协变量。
主要发现
- 活检组女性年龄更大,既往妊娠、分娩及自然流产史更常见,吸烟、卵巢储备减退及复发性妊娠丢失也更普遍。
- 小于胎龄儿校正OR 0.97(95%CI 0.85-1.12,P=.72),大于胎龄儿校正OR 1.10(95%CI 0.99-1.22,P=.09),均无显著关联。
- 早产<37周校正OR 0.93(95%CI 0.85-1.02,P=.11),两组相似。
- 低出生体重<2500g校正OR 0.80(95%CI 0.70-0.92,P<.001),极低出生体重<1500g校正OR 0.62(95%CI 0.46-0.83,P<.001),超低出生体重<1000g校正OR 0.48(95%CI 0.31-0.74,P<.001)。
- 中度早产<34周校正OR 0.76(95%CI 0.64-0.91,P=.003),极度早产<28周校正OR 0.63(95%CI 0.43-0.92,P=.02)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文结论指出相关机制需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Trophectoderm biopsy has become the mainstay assisted reproductive technique performed for preimplantation genetic testing, accounting for 43.8% of embryo transfer cycles in the United States in 2019 alone. Despite its prevalence, data on the obstetric and perinatal outcomes post-trophectoderm biopsy remains sparse and mixed. OBJECTIVE: This study aimed to examine the risks of adverse perinatal outcomes in birthweights and prematurity after transfers of the vitrified-thawed blastocyst with trophectoderm biopsy for preimplantation genetic testing. STUDY DESIGN: This was a retrospective observational cohort study of 45,712 singleton livebirths resulting from autologous vitrified-thawed blastocyst transfer cycles with or without trophectoderm biopsy for preimplantation genetic testing, reported by participating member clinics to the Society for Assisted Reproductive Technology national registry between 2014 and 2017. Adverse perinatal outcomes of preterm births and low birthweights were analyzed. Multivariable regression analyses were performed to control for covariates. Comparing the trophectoderm biopsy (n=21,584) and no trophectoderm biopsy (n=24,128) groups, adjusted odds ratios were calculated for the outcomes of small-for-gestational-age, large-for-gestational-age, low birthweight <2500 g, very low birthweight <1500 g, extremely low birthweight <1000 g, late preterm births <37 weeks, moderate preterm births <34 weeks, and extremely preterm births <28 weeks. RESULTS: Women in the trophectoderm biopsy group were older and more likely to have prior pregnancies, deliveries, and a history of spontaneous abortions. Tobacco use, diminished ovarian reserve, and recurrent pregnancy loss were also more prevalent in the trophectoderm biopsy group. Trophectoderm biopsy was not associated with small-for-gestational-age (adjusted odds ratio, 0.97; 95% confidence interval, 0.85-1.12; P=.72) or large-for-gestational-age newborns (adjusted odds ratio, 1.10; 95% confidence interval, 0.99-1.22; P=.09). Risks of preterm births <37 weeks gestation were similar between the biopsy and nonbiopsy groups (adjusted odds ratio, 0.93; 95% confidence interval, 0.85-1.02; P=.11). Trophectoderm biopsy was associated with a significantly lower risk of low birthweight <2500 g (adjusted odds ratio, 0.80; 95% confidence interval, 0.70-0.92; P<.001), very low birthweight <1500 g (adjusted odds ratio, 0.62; 95% confidence interval, 0.46-0.83; P<.001), extremely low birthweight <1000 g (adjusted odds ratio, 0.48; 95% confidence interval, 0.31-0.74; P<.001), moderate preterm birth <34 weeks (adjusted odds ratio, 0.76; 95% confidence interval, 0.64-0.91; P=.003), and extreme preterm birth <28 weeks (adjusted odds ratio, 0.63; 95% confidence interval, 0.43-0.92; P=.02). CONCLUSION: Trophectoderm biopsy is not associated with increased risks of small-for-gestational-age, large-for-gestational-age, or late preterm birth. Risks of low birthweight, very low birthweight, and extremely low birthweight from moderate and extreme preterm births are lower after trophectoderm biopsy, possibly by selecting against confined placental mosaicism or inducing placental epigenetic changes, the mechanisms of which warrant further investigation.
引用
- Liu AH, Shah T, Wu H, et al. Trophectoderm biopsy is associated with lower risks of moderate to extreme prematurity and low birthweights: a national registry cohort study of singleton livebirths from frozen-thawed blastocyst transfers. Am J Obstet Gynecol. 2024. PMID: 39029546. doi:10.1016/j.ajog.2024.07.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。